Research view
Switch to patient viewAlzheimer disease: trials that stopped early
Trials on Alzheimer disease that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.
Stopped early
86 stopped trials give a reason in the registry, latest registry update first.
Terminated
HOme-based Brain Monitoring With a GARment-EEG to Study Cognitive Decline in the Aging Population
Reason given in the registry “Due to time and funding constraints, recruitment for the cross-over phase closed before enrolling the planned 500 participants, and the longitudinal phase was not initiated. Not related to participant safety.”
Quoted unchanged from ClinicalTrials.gov; record updated 13 Nov 2026.
- Ended
- Dec 2025
- Run by
- Bitbrain
- Registry record
- NCT06993207
Suspended
Adaptation and Normalization of a Verbal Episodic Memory Test in French Sign Language
Reason given in the registry “Inclusions suspended during the period between phase 1 (adaptation of the test in French sign Language) and phase 2 (inclusion for the standardization of the test).”
Quoted unchanged from ClinicalTrials.gov; record updated 27 Oct 2026.
- Run by
- Poitiers University Hospital
- Registry record
- NCT06902753
Terminated
Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients.
Reason given in the registry “recruitment challenges”
Quoted unchanged from ClinicalTrials.gov; record updated 23 Oct 2026.
- Ended
- Aug 2026
- Run by
- Centre Hospitalier Universitaire de Nice
- Registry record
- NCT06523296
Terminated
Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease
Reason given in the registry “Lack of funding”
Quoted unchanged from ClinicalTrials.gov; record updated 21 Oct 2026.
- Ended
- Sept 2025
- Run by
- Johns Hopkins University
- Registry record
- NCT05978804
Withdrawn
GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
Reason given in the registry “poor accrual and funding issues”
Quoted unchanged from ClinicalTrials.gov; record updated 16 Oct 2026.
- Ended
- Jun 2026
- Run by
- West China Hospital
- Registry record
- NCT07677865
Suspended
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
Reason given in the registry “Administrative”
Quoted unchanged from ClinicalTrials.gov; record updated 21 Sept 2026.
- Run by
- ProgenaBiome
- Registry record
- NCT04031469
Withdrawn
DECIDE: Dyads and Families
Reason given in the registry “No participants were enrolled in the clinical trial portion. The community-engaged nature of the project required more time than anticipated, and funding was insufficient to support the implementation of the proposed intervention.”
Quoted unchanged from ClinicalTrials.gov; record updated 18 Sept 2026.
- Run by
- Emory University
- Registry record
- NCT05139290
Withdrawn
Implementation of AIP Services for Older Adults With AD
Reason given in the registry “Not a clinical trial so retiring ClinicalTrials.gov record”
Quoted unchanged from ClinicalTrials.gov; record updated 14 Sept 2026.
- Run by
- Northwestern University
- Registry record
- NCT07361601
Terminated
The Ketogenic Diet for Alzheimer's Disease
Reason given in the registry “lake of inclusions”
Quoted unchanged from ClinicalTrials.gov; record updated 10 Sept 2026.
- Ended
- Sept 2026
- Run by
- Assistance Publique - Hôpitaux de Paris
- Registry record
- NCT04701957
Withdrawn
REVERSE-Long COVID-19 With Baricitinib Study
Reason given in the registry “This submission for the pilot study has been withdrawn as the full trial opened under a different NCT number before participants enrolled in the pilot.”
Quoted unchanged from ClinicalTrials.gov; record updated 9 Sept 2026.
- Phase
- Phase 3
- Run by
- Vanderbilt University Medical Center
- Registry record
- NCT05858515
Terminated
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
Reason given in the registry “Treatment with 20 mg piromelatine did not demonstrate efficacy over treatment with placebo based on analysis with the ADAS-Cog 14 subscale and with other cognitive and neuropsychiatric parameters.”
Quoted unchanged from ClinicalTrials.gov; record updated 9 Sept 2026.
- Ended
- Dec 2024
- Phase
- Phase 2/3
- Run by
- Neurim Pharmaceuticals Ltd.
- Registry record
- NCT05267535
Terminated
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
Reason given in the registry “Sponsor business decision”
Quoted unchanged from ClinicalTrials.gov; record updated 25 Jun 2026.
- Ended
- Mar 2026
- Phase
- Phase 3
- Run by
- Alzheon Inc.
- Registry record
- NCT06304883
Terminated
An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study
Reason given in the registry “Study AXS-05-AD-305 was terminated due to completion of overall program objectives.”
Quoted unchanged from ClinicalTrials.gov; record updated 25 Jun 2026.
- Ended
- Apr 2025
- Phase
- Phase 3
- Run by
- Axsome Therapeutics, Inc.
- Registry record
- NCT06736509
Terminated
Implement and Test Visual Consent Template and Process
Reason given in the registry “Insufficient funding”
Quoted unchanged from ClinicalTrials.gov; record updated 3 Jun 2026.
- Ended
- Apr 2026
- Run by
- Washington University School of Medicine
- Registry record
- NCT06804837
Terminated
Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients
Reason given in the registry “Based on the adjustment of the sponsor's R\&D strategy, it is decided to terminate this study in advance.”
Quoted unchanged from ClinicalTrials.gov; record updated 13 May 2026.
- Ended
- Jan 2026
- Phase
- Phase 2
- Run by
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Registry record
- NCT06199037
Terminated
Integration of Health Information Technology and Promotion of Personhood in Family-Centered Dementia Care
Reason given in the registry “low enrollment”
Quoted unchanged from ClinicalTrials.gov; record updated 11 May 2026.
- Ended
- Sept 2025
- Run by
- Florida International University
- Registry record
- NCT04571502
Terminated
A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease
Reason given in the registry “Resource Constraints”
Quoted unchanged from ClinicalTrials.gov; record updated 6 May 2026.
- Ended
- Nov 2023
- Phase
- Phase 2
- Run by
- TrueBinding, Inc.
- Registry record
- NCT05476783
Terminated
A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01
Reason given in the registry “Study discontinued due to sponsor transition and strategic decision not to continue the protocol.”
Quoted unchanged from ClinicalTrials.gov; record updated 30 Apr 2026.
- Ended
- Jan 2026
- Phase
- Phase 1
- Run by
- Alzheimer's Disease Expert Lab (ADEL), Inc.
- Registry record
- NCT06247345
Terminated
Decision Making Tool for Firearm Storage
Reason given in the registry “Recruitment to the study was determined to not be feasible”
Quoted unchanged from ClinicalTrials.gov; record updated 28 Apr 2026.
- Ended
- Oct 2024
- Run by
- University of Washington
- Registry record
- NCT06382194
Terminated
Detecting Beta-amyloid in the Retina
Reason given in the registry “This study has been transferred to the Human Research Ethics Committee of St Vincent's Hospital Melbourne.”
Quoted unchanged from ClinicalTrials.gov; record updated 24 Apr 2026.
- Ended
- Jan 2024
- Run by
- Center for Eye Research Australia
- Registry record
- NCT07529912
Withdrawn
Virtual Communication in the Hospital: Impact on Patients and Surrogates
Reason given in the registry “Recruitment effort yielded no enrollments, so this study was stopped. We are re-evaluating the study design.”
Quoted unchanged from ClinicalTrials.gov; record updated 22 Apr 2026.
- Run by
- Indiana University
- Registry record
- NCT05395039
Terminated
A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.
Reason given in the registry “Company will improve study desig”
Quoted unchanged from ClinicalTrials.gov; record updated 9 Apr 2026.
- Ended
- Sept 2025
- Phase
- Phase 2
- Run by
- NeuroSense Therapeutics Ltd.
- Registry record
- NCT06185543
Suspended
The Dose Finding Study of DAOIB Added to tDCS for AD
Reason given in the registry “The trial was suspended due to the budget issue”
Quoted unchanged from ClinicalTrials.gov; record updated 20 Mar 2026.
- Phase
- Phase 2
- Run by
- Chang Gung Memorial Hospital
- Registry record
- NCT05006781
Terminated
Autonomous Navigating Robot for Detecting Falls and Risk of Falls in Nursing Home Residents With Alzheimer Disease/ADRD - Feasibility Study
Reason given in the registry “The robot had technical problems which couldn't be fixed and the study could not begin.”
Quoted unchanged from ClinicalTrials.gov; record updated 5 Mar 2026.
- Ended
- Aug 2025
- Run by
- Vigorous Mind, Inc.
- Registry record
- NCT07451223
Terminated
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Reason given in the registry “Sponsor resource allocation”
Quoted unchanged from ClinicalTrials.gov; record updated 27 Feb 2026.
- Ended
- Jul 2024
- Phase
- Phase 2
- Run by
- Inmune Bio, Inc.
- Registry record
- NCT05522387
Terminated
A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease
Reason given in the registry “Parent study failed to meet the primary endpoint and there were no treatment effects that favored AL002 on secondary clinical and functional endpoints.”
Quoted unchanged from ClinicalTrials.gov; record updated 25 Feb 2026.
- Ended
- Feb 2025
- Phase
- Phase 2
- Run by
- Alector Inc.
- Registry record
- NCT05744401
Suspended
Risk Screening & Primary Prevention of Elder Abuse in People Living With Dementia
Reason given in the registry “Study paused per IRB request.”
Quoted unchanged from ClinicalTrials.gov; record updated 24 Feb 2026.
- Run by
- University of Southern California
- Registry record
- NCT07429591
Terminated
Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) and Pharmacodynamics (PD) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer's Disease (AD)
Reason given in the registry “Sponsor decision to terminate study early. Decision not based on safety concerns.”
Quoted unchanged from ClinicalTrials.gov; record updated 20 Feb 2026.
- Ended
- Dec 2025
- Phase
- Phase 1
- Run by
- Ionis Pharmaceuticals, Inc.
- Registry record
- NCT06673069
Withdrawn
Dementia Prevention Internet-Based Intervention: Randomized Controlled Trial and Knowledge Translation
Reason given in the registry “Study did not receive funding.”
Quoted unchanged from ClinicalTrials.gov; record updated 2 Feb 2026.
- Ended
- Jan 2026
- Run by
- McMaster University
- Registry record
- NCT06911047
Terminated
Extension Study of Participants From SPG302-ALZ-101
Reason given in the registry “patients treated on compassionate use program”
Quoted unchanged from ClinicalTrials.gov; record updated 18 Dec 2025.
- Ended
- Oct 2025
- Phase
- Phase 2
- Run by
- Spinogenix
- Registry record
- NCT06833281
Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.